Press Releases

BOSTON, MA – May 7, 2014 – InspireMD, Inc. (NYSE MKT: NSPR) (“InspireMD” or the “Company”), a leader in embolic protection systems (“EPS”), today announced financial and operating results for the quarter ended March 31, 2014.   Recent Events Initiated enrollment of patients into the CARENET (CARotid Embolic protection study using MicroNet™) for the CGuardTM… Read More

Study of 97 patients resulted in zero mortalities in STEMI patients as of 30-day follow up Results to be presented at EuroPCR meeting in Paris on Thursday, May 22nd at 4:50 p.m. CEST BOSTON, Ma – May 7, 2014 – InspireMD, Inc. (“InspireMD” or the “Company”) (NYSE MKT: NSPR), a leader in embolic protection stents… Read More

BOSTON, MA – April 30, 2014 – InspireMD, Inc. (“InspireMD” or the “Company”) (NYSE MKT: NSPR), a leader in embolic protection systems (EPS), today announced that it has initiated a Voluntary Field Action (VFA) following recent reports  of MGuard Prime EPS stent dislodgements.  These reports have primarily occurred during the preparation of the MGuard Prime EPS, upon removal… Read More

BOSTON, MA – April 30, 2014 – InspireMD, Inc. (NYSE MKT: NSPR) (“InspireMD” or the “Company”), a leader in embolic protection stents, announced today that it will release its financial results for the quarter ended March 31, 2014 on Wednesday, May 7th.   The Company will host a conference call at 4:30 p.m. ET on Wednesday,… Read More

Proven Embolic Protection System Expands to Treat Carotid Artery Disease   BOSTON, MA – March 19, 2014 – InspireMD, Inc. (“InspireMD” or the “Company”) (NYSE MKT: NSPR), a leader in embolic protection systems, today announced that it has successfully enrolled the first patient into the CARENET (CARotid Embolic protection study using microNET) multi-center European clinical trial for the… Read More

BOSTON, MA – March 6, 2014 – InspireMD, Inc. (NYSE MKT: NSPR) (“InspireMD” or the “Company”), today announced that its CEO, Alan Milinazzo, will be presenting at the 26th Annual ROTH Conference at the Ritz Carlton, Laguna Niguel in Dana Point, CA. The Company will present at 5:00 p.m. PT on Tuesday, March 11, 2014…. Read More

BOSTON, MA – February 27, 2014 – InspireMD, Inc. (NYSE MKT: NSPR) (“InspireMD” or the “Company”), today announced that its CEO, Alan Milinazzo, will be presenting at the Cowen & Company 34th Annual Health Care Conference at The Boston Marriott Copley Place, in Boston. The Company will present at 9:20 a.m. EST on Wednesday, March… Read More

BOSTON, MA – February 26, 2014 – InspireMD Inc. (NYSE MKT: NSPR) (“InspireMD” or the “Company”), a leader in embolic protection systems, today announced financial and operating results for the quarter and the six month period ended December 31, 2013.   Recent Highlights MASTER II trial on track to complete enrollment in the fourth quarter… Read More

BOSTON, MA – February 18, 2014 – InspireMD, Inc. (NYSE MKT: NSPR) (“InspireMD” or the “Company”), a leader in embolic protection stents, announced today that it will release its financial results for the six month period ended December 31, 2013 on February 26, 2014.   The Company will host a conference call at 4:30 p.m. ET… Read More

Acclaimed Embolic Protection System Expands to Treat Carotid Artery Disease   BOSTON, MA – February 5, 2014 – InspireMD, Inc. (“InspireMD” or the “Company”) (NYSE MKT: NSPR), a leader in embolic protection systems, today announced that its new CGuardTM carotid embolic protection system has been successfully implanted in  recent procedures, including a patient treated during the 17th Annual… Read More